Overin solution for injections 5 ampl 2ml 250mg sodium oxodihydroacridinyl acetate Оверин

Overin Indications

Treatment (in combination therapy):

- influenza and other acute respiratory viral diseases, including against the background of immunodeficiency states;
- infections caused by the Nerrex simplex virus, Vrellella zoosthere, Nerrex simplex genitalis, including those with impaired immune system;
- cytomegalovirus infection in people with immunodeficiency;
- radiation immune deficiency;
- HIV infection;
- encephalitis and encephalomyelitis viral etiology;
- acute and chronic hepatitis B and C;
- urethritis, epididymitis, prostatitis, cervicitis and salpingitis of chlamydial etiology;
- venereal lymphogranuloma;
- oncological diseases;
- multiple sclerosis;
- Candida lesions of the skin and mucous membranes;
- papillomavirus infection.

Contradictions

Hypersensitivity to the drug.

Autoimmune diseases. Pregnancy and breastfeeding. Children's age. Renal impairment

Dosage & Administration

Intramuscularly for 250 mg (1 vial) or 4 ̶ 6 mg / kg body weight. If necessary, a single dose of the drug Overin can be increased to 500 mg.

The course of treatment consists of 5 ̶ 7 injections of the drug Overin at a dose of 250 mg at an interval of 48 hours, the course dose depends on the clinical situation and the course of the disease.

Duration of treatment - 8 ̶ 12 days.